A Prospective, Multicenter, Observational Study on the Treatment of Chronic Common Femoral Artery Bifurcation Occlusion
RecruitingOBSERVATIONAL
Enrollment
300
Participants
Timeline
Start Date
February 15, 2022
Primary Completion Date
February 14, 2024
Study Completion Date
February 14, 2026
Conditions
Common Femoral Artery Occlusive Disease
Trial Locations (1)
Unknown
RECRUITING
Hiser Medical Group, Qingdao
All Listed Sponsors
lead
Qingdao Hiser Medical Group
OTHER
NCT05603546 - A Prospective, Multicenter, Observational Study on the Treatment of Chronic Common Femoral Artery Bifurcation Occlusion | Biotech Hunter | Biotech Hunter